Thomas W. Dubensky
Publications by Year
Research Areas
interferon and immune responses, Virus-based gene therapy research, Immunotherapy and Immune Responses, Cancer Research and Treatments, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity(2015)1,453 cited
- → STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade(2015)688 cited
- → Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer(2015)589 cited
- → The host STING pathway at the interface of cancer and immunity(2016)479 cited
- → Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity(2018)421 cited
- → Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity(2006)391 cited
- → A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction(2011)364 cited
- → Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas(2021)338 cited
- → Listeria-based cancer vaccines that segregate immunogenicity from toxicity(2004)295 cited
- → Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways(2002)269 cited